Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIV

Abstract HIV post- exposure prophylaxis (PEP) is a prevention tool for individuals with a recent potential exposure to HIV. Doravirine has been available since 2019 in combination with tenofovir disoproxil fumarate and lamivudine and has not been evaluated as a PEP. DOR/3TC/TDF is our department’s m...

Descripció completa

Dades bibliogràfiques

Autors principals:	Inès Devred, Kick Kayembe, Nadia Valin, Hayette Rougier, Bruce Wuembulua Shinga, Sidonie Lambert-Niclot, Thibault Chiarabini, Marie-Caroline Meyohas, Karine Lacombe
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2023-09-01
Col·lecció:	BMC Infectious Diseases
Matèries:	Post-exposure prophylaxis Doravirine HIV Adherence Completion rate
Accés en línia:	https://doi.org/10.1186/s12879-023-08544-x
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!